243 filings
Page 7 of 13
UPLOAD
i6rip p0cvqqpecbuo
14 Apr 22
Letter from SEC
12:00am
CORRESP
4p4wfmxp
14 Apr 22
Correspondence with SEC
12:00am
8-K
rezt0k3
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
ze2 yt9u3
7 Apr 22
Prospectus supplement
4:46pm
8-K
nlbfsmz30b39 t6z9p
22 Mar 22
Entry into a Material Definitive Agreement
6:05am
8-K
zu68k0clse4wk
18 Mar 22
InMed Announces Management Changes
1:02pm
8-K
mo2aih31 4bbhzzlk
9 Mar 22
InMed to Present at the 34th Annual Roth Conference
12:58pm
8-K
ygk54
23 Feb 22
Departure of Directors or Certain Officers
1:10pm
8-K
a0qjv 748msq4z7n8
15 Feb 22
Regulation FD Disclosure
1:17pm
8-K
ur9 09x7uz
15 Feb 22
InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update
12:00am
EFFECT
jkwpy3 5qssm8qo
14 Feb 22
Notice of effectiveness
12:15am
EFFECT
4bw6vzl1a hjcv0v
11 Feb 22
Notice of effectiveness
12:00am
8-K
dpmz256zxiz1q 5cn8
10 Feb 22
Regulation FD Disclosure
12:34pm
CORRESP
knzfv
10 Feb 22
Correspondence with SEC
12:00am
CORRESP
phkyx
9 Feb 22
Correspondence with SEC
12:00am
UPLOAD
7d2inmuc60qq5h0xlba
8 Feb 22
Letter from SEC
12:00am
UPLOAD
rb5 kgq73
8 Feb 22
Letter from SEC
12:00am